{"filing":{"accession_number":"0000877860-26-000167","cik":"0000877860","ticker":"NHI","company_name":"NATIONAL HEALTH INVESTORS INC","form":"8-K","filing_date":"2026-07-01","report_date":null,"primary_document":"nhi-20260701.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/877860/000087786026000167/nhi-20260701.htm"},"events":[{"id":15510,"run_id":13837,"accession_number":"0000877860-26-000167","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses a Change in Control Severance Agreement entered into with Todd Siefert on July 1, 2026, specifying compensatory arrangements including severance multiples (2.0x base salary and bonus), bonus payments, COBRA continuation, and accelerated equity vesting upon qualifying termination events. This is a classic executive compensation disclosure under Item 5.02(e), distinct from a departure or appointment, as it establishes the terms of a severance and change-of-control arrangement.","company_name":"NATIONAL HEALTH INVESTORS INC","ticker":"NHI","filing_date":"2026-07-01","form":"8-K","submitted_at":null,"items":[{"id":13319,"accession_number":"0000877860-26-000167","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a Change in Control Severance Agreement entered into with Todd Siefert on July 1, 2026, specifying compensatory arrangements including severance multiples (2.0x base salary and bonus), bonus payments, COBRA continuation, and accelerated equity vesting upon qualifying termination events. This is a classic executive compensation disclosure under Item 5.02(e), distinct from a departure or appointment, as it establishes the terms of a severance and change-of-control arrangement.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T00:00:21.555648+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13319,"accession_number":"0000877860-26-000167","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a Change in Control Severance Agreement entered into with Todd Siefert on July 1, 2026, specifying compensatory arrangements including severance multiples (2.0x base salary and bonus), bonus payments, COBRA continuation, and accelerated equity vesting upon qualifying termination events. This is a classic executive compensation disclosure under Item 5.02(e), distinct from a departure or appointment, as it establishes the terms of a severance and change-of-control arrangement.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T00:00:21.555648+00:00","company_name":"NATIONAL HEALTH INVESTORS INC","ticker":"NHI","filing_date":"2026-07-01"}]}